Silence Therapeutics (SLNCF) Q3 2025 Earnings

7AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.09
-0.05
-0.01
0.02

Details

Expected EPS
-0.04482192
Actual EPS
-0.0648689184
Surprise EPS
-0.02
Surprise Percent
+44.73%

Description

Silence Therapeutics (SLNCF) has reported earnings of -0.0648689184 per share for Q3 2025.

0 Comments

Share your thoughts